The Valley Desk

ArticleCancer gene therapyPublished

mTORC1/2 inhibition induces tumor regression in CDK4/6 inhibitor-insensitive acral melanoma

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
Cancer gene therapy
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Melanoma; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays; Signal Transduction; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2
PubMed ID
41286504
Added to directory
Source checked

Report a correction or request removal